Close

Leerink Remains Cautious on Intercept Pharma (ICPT) Amid Positive CHMP Opinion on Ocaliva

Go back to Leerink Remains Cautious on Intercept Pharma (ICPT) Amid Positive CHMP Opinion on Ocaliva

Form 8-K INTERCEPT PHARMACEUTICAL For: Oct 07

October 13, 2016 5:21 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13... More

Form 4 INTERCEPT PHARMACEUTICAL For: Oct 10 Filed by: Shapiro David

October 12, 2016 9:01 PM EDT

.FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align: right; } .SmallFormData { color: blue; background-color: white; font-size: 10px; font-family: Times, serif; } .FootnoteData { color: green; background-color: white; font-size: 10px; font-family: Times, serif; } .FormNumText { font-size: 12px; font-weight: bold; font-family: arial, helvetica, sans-serif; } .FormAttention { font-size: 12px; font-weight: bold; font-family: helvetica; } .FormText { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left; } .FormTextR { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right; } .FormTextC { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center; } .FormEMText { font-size: 12px; font-style: italic; font-weight: normal;... More